Cargando…
Adipose specific disruption of seipin causes early-onset generalised lipodystrophy and altered fuel utilisation without severe metabolic disease
OBJECTIVE: Mutations to the BSCL2 gene disrupt the protein seipin and cause the most severe form of congenital generalised lipodystrophy (CGL). Affected individuals exhibit a near complete loss of white adipose tissue (WAT) and suffer from metabolic disease. Seipin is critical for adipocyte developm...
Autores principales: | Mcilroy, George D., Suchacki, Karla, Roelofs, Anke J., Yang, Wulin, Fu, Yanyun, Bai, Bo, Wallace, Robert J., De Bari, Cosimo, Cawthorn, William P., Han, Weiping, Delibegović, Mirela, Rochford, Justin J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5985228/ https://www.ncbi.nlm.nih.gov/pubmed/29459250 http://dx.doi.org/10.1016/j.molmet.2018.01.019 |
Ejemplares similares
-
Ablation of Bscl2/seipin in hepatocytes does not cause metabolic dysfunction in congenital generalised lipodystrophy
por: Mcilroy, George D., et al.
Publicado: (2020) -
Towards a mechanistic understanding of lipodystrophy and seipin functions
por: Wee, Kenneth, et al.
Publicado: (2014) -
Gene therapy restores adipose tissue and metabolic health in a pre-clinical mouse model of lipodystrophy
por: Sommer, Nadine, et al.
Publicado: (2022) -
Oligomers of the lipodystrophy protein seipin may co-ordinate GPAT3 and AGPAT2 enzymes to facilitate adipocyte differentiation
por: Sim, M. F. Michelle, et al.
Publicado: (2020) -
Bscl2 Deficiency Does Not Directly Impair the Innate Immune Response in a Murine Model of Generalized Lipodystrophy
por: Roumane, Ahlima, et al.
Publicado: (2021)